periosteal electrical dry needling with no maintenance treatments for Knee

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Team Rehabilitation, Chamblee, GA
Knee+2 More
periosteal electrical dry needling with no maintenance treatments - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this research is to treat patients with knee osteoarthritis (OA) with periosteal electric dry needling (PEDN). It is also to determine the optimal "maintenance" regiment (i.e. maintenance treatments, one maintenance treatment every other month, or one maintenance treatment per month) required to maintain improvements in pain and function following PEDN. Physical therapists commonly use PEDN to treat knee OA, and previous studies suggest that this treatment is useful for reducing pain and improving function in patients with osteoarthritis. However, an appropriate maintenance treatment strategy to maintain these outcomes is presently unknown.

Eligible Conditions

  • Knee

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: 6 weeks, 14 weeks, 22 weeks, 30 weeks

Week 30
Change in GROC (Global Rating of Change score)
baseline, 30 weeks
Change in Medication Intake (Frequency of medication intake during last time period)
Week 30
Change in WOMAC Knee Osteoarthritis Index (Pain)
Change in WOMAC Knee Osteoarthritis Index (Physical Function)
Change in WOMAC Knee Osteoarthritis Index (Stiffness)
Change in WOMAC Knee Osteoarthritis Index (Total Score)
Change in knee pain

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Periosteal electrical dry needling followed by maintenance treatments every othe...
1 of 3
Periosteal electrical dry needling followed by monthly maintenance treatments
1 of 3
Periosteal electrical dry needling followed by no maintenance treatments
1 of 3
Active Control
Experimental Treatment

120 Total Participants · 3 Treatment Groups

Primary Treatment: periosteal electrical dry needling with no maintenance treatments · No Placebo Group · N/A

Periosteal electrical dry needling followed by no maintenance treatments
Other
Experimental Group · 1 Intervention: periosteal electrical dry needling with no maintenance treatments · Intervention Types: Other
Periosteal electrical dry needling followed by maintenance treatments every other month
Other
ActiveComparator Group · 1 Intervention: periosteal electrical dry needling with maintenance treatments every other month · Intervention Types: Other
Periosteal electrical dry needling followed by monthly maintenance treatments
Other
ActiveComparator Group · 1 Intervention: periosteal electrical dry needling with monthly maintenance treatments · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 weeks, 14 weeks, 22 weeks, 30 weeks
Closest Location: Team Rehabilitation · Chamblee, GA
Photo of georgia 1Photo of georgia 2Photo of georgia 3
N/AFirst Recorded Clinical Trial
0 TrialsResearching Knee
0 CompletedClinical Trials

Who is running the clinical trial?

Universidad Rey Juan CarlosOTHER
95 Previous Clinical Trials
7,689 Total Patients Enrolled
Alabama Physical Therapy & AcupunctureLead Sponsor
13 Previous Clinical Trials
1,447 Total Patients Enrolled
James Dunning, PhD DPTPrincipal InvestigatorAmerican Academy of Manipulative Therapy

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a bone scan showing bony enlargement.
You have a palpable, audible, and palpable crepitus on active motion.
You have no palpable warmth of the Synovium.
You have knee pain of at least 2/10 per NPRS (0---10 scale) for >3 months.
At least 3 of the following criteria must be met:\n- I.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.